BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 15226229)

  • 1. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
    Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
    Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac disease in patients with tumors and tumor therapy].
    Hoppe UC
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():31-5. PubMed ID: 16802515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline cardiotoxicity in childhood.
    Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R
    Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting and preventing the cardiotoxicity of cancer therapy.
    Anderson B; Sawyer DB
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of radiation and anthracycline cardiotoxicity.
    Berry GJ; Jorden M
    Pediatr Blood Cancer; 2005 Jun; 44(7):630-7. PubMed ID: 15825155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
    Yeh ET; Bickford CL
    J Am Coll Cardiol; 2009 Jun; 53(24):2231-47. PubMed ID: 19520246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.
    Raschi E; Vasina V; Ursino MG; Boriani G; Martoni A; De Ponti F
    Pharmacol Ther; 2010 Feb; 125(2):196-218. PubMed ID: 19874849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of cardiotoxicity from antineoplastic therapy.
    Chanan-Khan A; Srinivasan S; Czuczman MS
    J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac toxicity in cancer therapy].
    Łacko A; Włodarska I; Zymliński R; Mazur G; Wróbel T; Gisterek I
    Pol Merkur Lekarski; 2002 Jul; 13(73):79-85. PubMed ID: 12362515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.
    Jones RL; Ewer MS
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1249-69. PubMed ID: 17020459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac disease in patients with tumors and tumor therapy].
    Hoppe UC
    Internist (Berl); 2007 Mar; 48(3):268-75. PubMed ID: 17287966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of cardiotoxicity induced by anthracyclines.
    Elliott P
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer therapy induced cardiotoxicity: review of the literature.
    Geiger S; Lange V; Suhl P; Heinemann V; Stemmler HJ
    Anticancer Drugs; 2010 Jul; 21(6):578-90. PubMed ID: 20375725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity after childhood cancer: beginning with the end in mind.
    Lipshultz SE; Adams MJ
    J Clin Oncol; 2010 Mar; 28(8):1276-81. PubMed ID: 20142585
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oncologic treatment of oto-neuro-ophthalmological metastases and their complications].
    Borràs J; Gumà J; Lainez N; Villar JL; Sabater S
    Rev Neurol; 2000 Dec 16-31; 31(12):1267-75. PubMed ID: 11205576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of systemic cancer treatment.
    Senkus E; Jassem J
    Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.